Prestige Consumer Healthcare (PBH) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Prestige Consumer Healthcare Revenue Highlights


Latest Revenue (Y)

$1.13B

Latest Revenue (Q)

$283.55M

Main Segment (Y)

Women's Health

Main Geography (Y)

North American OTC Healthcare

Prestige Consumer Healthcare Revenue by Period


Prestige Consumer Healthcare Revenue by Year

DateRevenueChange
2024-03-31$1.13B-0.21%
2023-03-31$1.13B3.76%
2022-03-31$1.09B15.21%
2021-03-31$943.37M-2.04%
2020-03-31$963.01M-1.31%
2019-03-31$975.78M-6.28%
2018-03-31$1.04B18.04%
2017-03-31$882.06M9.40%
2016-03-31$806.25M12.82%
2015-03-31$714.62M18.73%
2014-03-31$601.88M-3.48%
2013-03-31$623.60M41.38%
2012-03-31$441.08M31.08%
2011-03-31$336.51M11.42%
2010-03-31$302.02M-3.42%
2009-03-31$312.71M-4.25%
2008-03-31$326.60M2.50%
2007-03-31$318.63M7.40%
2006-03-31$296.67M-2.19%
2005-03-31$303.32M244.99%
2004-03-31$87.92M22.56%
2003-03-31$71.73M55.09%
2002-03-31$46.25M434.41%
2001-03-31$8.65M-

Prestige Consumer Healthcare generated $1.13B in revenue during NA 2024, up -0.21% compared to the previous quarter, and up 115.33% compared to the same period a year ago.

Prestige Consumer Healthcare Revenue by Quarter

DateRevenueChange
2024-09-30$283.55M6.14%
2024-06-30$267.14M-3.56%
2024-03-31$276.99M-2.03%
2023-12-31$282.74M-1.25%
2023-09-30$286.32M2.51%
2023-06-30$279.31M-2.29%
2023-03-31$285.87M3.75%
2022-12-31$275.52M-4.75%
2022-09-30$289.27M4.41%
2022-06-30$277.06M3.79%
2022-03-31$266.94M-2.74%
2021-12-31$274.47M-0.64%
2021-09-30$276.23M2.62%
2021-06-30$269.18M13.21%
2021-03-31$237.76M-0.43%
2020-12-31$238.79M0.58%
2020-09-30$237.42M3.50%
2020-06-30$229.39M-8.69%
2020-03-31$251.24M4.01%
2019-12-31$241.55M1.46%
2019-09-30$238.07M2.55%
2019-06-30$232.15M-3.68%
2019-03-31$241.03M-0.16%
2018-12-31$241.41M0.86%
2018-09-30$239.36M-5.76%
2018-06-30$253.98M-0.78%
2018-03-31$255.97M-5.41%
2017-12-31$270.62M4.88%
2017-09-30$258.03M0.57%
2017-06-30$256.57M6.61%
2017-03-31$240.67M11.03%
2016-12-31$216.76M0.80%
2016-09-30$215.05M2.61%
2016-06-30$209.57M0.83%
2016-03-31$207.85M3.83%
2015-12-31$200.19M-2.85%
2015-09-30$206.06M7.25%
2015-06-30$192.13M1.10%
2015-03-31$190.05M-3.83%
2014-12-31$197.61M9.01%
2014-09-30$181.27M24.41%
2014-06-30$145.70M1.00%
2014-03-31$144.26M-1.34%
2013-12-31$146.21M-13.20%
2013-09-30$168.44M17.82%
2013-06-30$142.97M-7.47%
2013-03-31$154.51M-3.57%
2012-12-31$160.23M-1.00%
2012-09-30$161.85M10.11%
2012-06-30$147.00M9.70%
2012-03-31$134.00M26.11%
2011-12-31$106.25M0.67%
2011-09-30$105.54M10.76%
2011-06-30$95.30M-1.11%
2011-03-31$96.36M6.35%
2010-12-31$90.61M15.71%
2010-09-30$78.30M6.64%
2010-06-30$73.42M2.86%
2010-03-31$71.38M-5.39%
2009-12-31$75.45M-10.37%
2009-09-30$84.18M14.96%
2009-06-30$73.22M3.35%
2009-03-31$70.85M-11.74%
2008-12-31$80.28M-8.83%
2008-09-30$88.05M19.74%
2008-06-30$73.53M-8.58%
2008-03-31$80.43M-

Prestige Consumer Healthcare generated $283.55M in revenue during Q2 2025, up 6.14% compared to the previous quarter, and up 101.52% compared to the same period a year ago.

Prestige Consumer Healthcare Revenue Breakdown


Prestige Consumer Healthcare Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 24Mar 23Mar 22Mar 21Mar 20
Analgesics$117.45M----
Cough and Cold$119.02M----
Dermatologicals$129.10M----
Eye and Ear Care$179.42M----
Gastrointestinal$231.61M----
Oral Care$96.31M----
Other OTC$12.03M----
Women's Health$240.42M----
Product and Service, Other-$107.00K$42.00K$41.00K$74.00K
Product-$1.13B$1.09B$943.32M$962.94M

Prestige Consumer Healthcare's latest annual revenue breakdown by segment (product or service), as of Mar 24: Women's Health (21.36%), Gastrointestinal (20.58%), Eye and Ear Care (15.94%), Dermatologicals (11.47%), Cough and Cold (10.58%), Analgesics (10.44%), Oral Care (8.56%), and Other OTC (1.07%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Analgesics$28.22M$55.82M$30.27M$31.36M----------------
Women's Health$60.35M$120.08M$58.27M$62.07M----------------
Other OTC$3.16M$6.17M$3.11M$2.75M----------------
Oral Care$24.08M$50.06M$23.46M$22.78M----------------
Gastrointestinal$60.06M$117.22M$61.63M$52.76M----------------
Eye and Ear Care$42.79M$87.48M$45.07M$46.87M----------------
Dermatologicals$35.85M$66.85M$27.77M$34.49M----------------
Cough and Cold$29.27M$52.61M$33.17M$33.23M----------------
Product----$279.30M$285.83M$275.50M$289.26M$277.02M$266.93M$274.45M$276.22M$269.17M$237.75M$238.78M$237.41M$229.38M$251.21M$241.54M$238.05M
Product and Service, Other----$10.00K$34.00K$29.00K$9.00K$35.00K$9.00K$16.00K$8.00K$9.00K$9.00K$9.00K$13.00K$10.00K$28.00K$7.00K$18.00K

Prestige Consumer Healthcare's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Women's Health (21.27%), Gastrointestinal (21.16%), Eye and Ear Care (15.08%), Dermatologicals (12.63%), Cough and Cold (10.32%), Analgesics (9.94%), Oral Care (8.49%), and Other OTC (1.11%).

Prestige Consumer Healthcare Revenue Breakdown by Country

Annual Revenue by Country

CountryMar 24Mar 23Mar 22Mar 21Mar 20
North American OTC Healthcare$958.26M----
Non-US-$174.50M$176.71M$144.33M$150.36M
UNITED STATES-$953.22M$910.11M$799.04M$812.65M

Prestige Consumer Healthcare's latest annual revenue breakdown by geography, as of Mar 24: North American OTC Healthcare (100.00%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
North American OTC Healthcare$239.81M$422.32M$236.56M$244.42M$54.95M$242.32M$53.92M$59.38M$61.18M-----------
Non-US---------$47.36M$46.76M$40.07M$42.51M$38.65M$41.49M$34.13M$30.05M$42.84M$37.63M$38.35M
UNITED STATES---------$219.57M$227.72M$236.15M$226.67M$199.11M$197.30M$203.29M$199.35M$208.39M$203.92M$199.71M

Prestige Consumer Healthcare's latest quarterly revenue breakdown by geography, as of Sep 24: North American OTC Healthcare (100.00%).

Prestige Consumer Healthcare Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
PBHPrestige Consumer Healthcare$1.13B$283.55M
PAHCPhibro Animal Health$977.89M$273.16M
EVOEvotec SE$781.43M$208.73M
PCRXPacira BioSciences$674.98M$168.57M
SUPNSupernus Pharmaceuticals$607.52M$175.69M
AMPHAmphastar Pharmaceuticals$593.24M$188.82M
COLLCollegium Pharmaceutical$566.77M$159.30M
ANIPANI Pharmaceuticals$486.82M$148.33M
EGRXEagle Pharmaceuticals$316.61M$64.65M
DCPHDeciphera Pharmaceuticals$163.36M$45.00M
SSICSilver Spike Investment$11.72M$2.76B
RGCRegencell Bioscience--

PBH Revenue FAQ


What is Prestige Consumer Healthcare’s yearly revenue?

Prestige Consumer Healthcare's yearly revenue for 2024 was $1.13B, representing a decrease of -0.21% compared to 2023. The company's yearly revenue for 2023 was $1.13B, representing an increase of 3.76% compared to 2022. PBH's yearly revenue for 2022 was $1.09B, representing an increase of 15.21% compared to 2021.

What is Prestige Consumer Healthcare’s quarterly revenue?

Prestige Consumer Healthcare's quarterly revenue for Q2 2025 was $283.55M, a 6.14% increase from the previous quarter (Q1 2025), and a -0.97% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $267.14M, a -3.56% decrease from the previous quarter (Q4 2024), and a -4.36% decrease year-over-year (Q1 2024). PBH's quarterly revenue for Q4 2024 was $276.99M, a -2.03% decrease from the previous quarter (Q3 2024), and a -3.11% decrease year-over-year (Q4 2023).

What is Prestige Consumer Healthcare’s revenue growth rate?

Prestige Consumer Healthcare's revenue growth rate for the last 3 years (2022-2024) was 3.55%, and for the last 5 years (2020-2024) was 16.86%.

What are Prestige Consumer Healthcare’s revenue streams?

Prestige Consumer Healthcare's revenue streams in r 24 are Analgesics, Cough and Cold, Dermatologicals, Eye and Ear Care, Gastrointestinal, Oral Care, Other OTC, and Women's Health. Analgesics generated $117.45M in revenue, accounting 10.44% of the company's total revenue Cough and Cold generated $119.02M in revenue, accounting 10.58% of the company's total revenue Dermatologicals generated $129.1M in revenue, accounting 11.47% of the company's total revenue Eye and Ear Care generated $179.42M in revenue, accounting 15.94% of the company's total revenue Gastrointestinal generated $231.61M in revenue, accounting 20.58% of the company's total revenue Oral Care generated $96.3M in revenue, accounting 8.56% of the company's total revenue Other OTC generated $12.02M in revenue, accounting 1.07% of the company's total revenue Women's Health generated $240.42M in revenue, accounting 21.36% of the company's total revenue

What is Prestige Consumer Healthcare’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of Prestige Consumer Healthcare was Women's Health. This segment made a revenue of $240.42M, representing 21.36% of the company's total revenue.